CARM1通过调控Bax/Bcl-2表达和Caspase-3活性进而调控肝癌生长作用
CARM1 Regulates the Growth of Hepatocellular Carcinoma Cells via Regulation of Bax/Bcl-2 Level and Caspase-3 Activity
DOI: 10.12677/WJCR.2019.93013, PDF,    科研立项经费支持
作者: 刘美玲, 洪宏海*, 王 征:广州医科大学附属第三医院检验科,广东 广州
关键词: 肝癌CARM1Bcl-2BaxCaspase-3HCC CARM1 Bcl-2 Bax Caspase-3
摘要: 目的:共激活因子相关精氨酸甲基转移酶1 (Coactivator-associated arginine methyltransferase 1, CARM1)在肝癌细胞中生长作用及机制研究。方法:qRT-PCR、western blot法检测肝癌细胞中CARM1表达;MTT法和台盼蓝实验检测肝癌细胞的生长情况;Caspase-3试剂盒检测Caspase-3活性;小分子干扰RNA干扰CARM1研究其作用和分子机制。结果:小分子干扰RNA明显敲低CARM1水平;干扰CARM1后明显抑制肝癌细胞生长,且下调抑凋亡蛋白Bcl-2和上调促凋亡蛋白Bax表达水平,同时激活Caspase-3活性。结论:CARM1通过调控Bax/Bcl-2表达和Caspase-3活性进而调控肝癌生长作用。
Abstract: Objective: To investigate the effect and mechanism of CARM1 on the growth of HCC. Methods: qRT-PCR and western blot were used to detect the expression of CARM1. MTT assay and Trypan blue assay were used to detect the growth of hepatocellular carcinoma cells; Caspase-3 kit was used to detect the activity of Caspase-3; small interfering RNA interference CARM1 was used to study its role and molecular mechanism on HCC growth. Results: Small interfering RNA significantly knocked down the level of CARM1; interfering with CARM1 significantly, which inhibited the growth of hepatocellular carcinoma cells, down-regulated Bcl-2, up-regulated Bax expression, and activated Caspase-3 activity. Conclusion: CARM1 regulates the growth of hepatocellular carcinoma by regulating the expression of Bax/Bcl-2 and the activity of Caspase-3.
文章引用:刘美玲, 洪宏海, 王征. CARM1通过调控Bax/Bcl-2表达和Caspase-3活性进而调控肝癌生长作用[J]. 世界肿瘤研究, 2019, 9(3): 90-97. https://doi.org/10.12677/WJCR.2019.93013

参考文献

[1] Rodriguez-Paredes, M. and Esteller, M. (2011) Cancer Epigenetics Reaches Mainstream Oncology. Nature Medicine, 17, 330-339.
[Google Scholar] [CrossRef] [PubMed]
[2] Fraga, M.F., et al. (2005) Loss of Acetylation at Lys16 and Trimethylation at Lys20 of Histone H4 Is a Common Hallmark of Human Cancer. Nature Genetics, 37, 391-400.
[Google Scholar] [CrossRef] [PubMed]
[3] Kelly, T.K., De Carvalho, D.D. and Jones, P.A. (2010) Epigenetic Modifications as Therapeutic Targets. Nature Biotechnology, 28, 1069-1078.
[Google Scholar] [CrossRef] [PubMed]
[4] Suzuki, S., et al. (2004) Specific Differences in Gene Expression Profile Revealed by cDNA Microarray Analysis of Glutathione S-Transferase Placental form (GST-P) Immunohistochemically Positive Rat Liver Foci and Surrounding Tissue. Carcinogenesis, 25, 439-443.
[Google Scholar] [CrossRef] [PubMed]
[5] Xu, W., et al. (2001) A Transcriptional Switch Mediated by Cofactor Methylation. Science, 294, 2507-2511.
[Google Scholar] [CrossRef] [PubMed]
[6] Koh, S.S., et al. (2002) Synergistic Coactivator Function by Coactivator-Associated Arginine Methyltransferase (CARM) 1 and β-Catenin with Two Different Classes of DNA-Binding Transcriptional Activators. The Journal of Biological Chemistry, 277, 26031-26035.
[Google Scholar] [CrossRef
[7] Covic, M., et al. (2005) Arginine Methyltransferase CARM1 Is a Promoter-Specific Regulator of NF-κB-Dependent Gene Expression. The EMBO Journal, 24, 85-96.
[Google Scholar] [CrossRef] [PubMed]
[8] Wang, Y.P., et al. (2016) Arginine Methylation of MDH1 by CARM1 Inhibits Glutamine Metabolism and Suppresses Pancreatic Cancer. Molecular Cell, 64, 673-687.
[Google Scholar] [CrossRef] [PubMed]
[9] Frietze, S., et al. (2008) CARM1 Regulates Estrogen-Stimulated Breast Cancer Growth through Up-Regulation of E2F1. Cancer Research, 68, 301-306.
[Google Scholar] [CrossRef
[10] Wang, L., et al. (2016) CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis. Cancer Cell, 30, 179-180.
[Google Scholar] [CrossRef] [PubMed]
[11] Li, S., et al. (2017) The Overexpression of CARM1 Promotes Human Osteosarcoma Cell Proliferation through the pGSK3β/β-Catenin/CyclinD1 Signaling Pathway. International Journal of Biological Sciences, 13, 976-984.
[Google Scholar] [CrossRef] [PubMed]
[12] Osada, S., et al. (2006) Altered Gene Expression of Transcriptional Regulatory Factors in Tumor Marker-Positive Cells during Chemically Induced Hepatocarcinogenesis. Toxicology Letters, 167, 106-113.
[Google Scholar] [CrossRef] [PubMed]
[13] Wei, X., et al. (2018) SKP2 Promotes Hepatocellular Carcinoma Progression through Nuclear AMPK-SKP2-CARM1 Signaling Transcriptionally Regulating Nutrient-Deprived Autophagy Induction. Cellular Physiology and Biochemistry, 47, 2484-2497.
[Google Scholar] [CrossRef] [PubMed]
[14] Stockert, J.C., et al. (2012) MTT Assay for Cell Viability: Intracellular Localization of the Formazan Product Is in Lipid Droplets. Acta Histochemica, 114, 785-796.
[Google Scholar] [CrossRef] [PubMed]
[15] Jian, W., et al. (2019) A Novel Role of HuR in Epigallocatechin-3-Gallate (EGCG) Induces Tumour Cells Apoptosis. Journal of Cellular and Molecular Medicine, 23, 3767-3771.
[Google Scholar] [CrossRef] [PubMed]
[16] Llovet, J.M., Burroughs, A. and Bruix, J. (2003) Hepatocellular Carcinoma. The Lancet, 362, 1907-1917.
[Google Scholar] [CrossRef
[17] Han, T.S., et al. (2018) The Epigenetic Regulation of HCC Metastasis. International Journal of Molecular Sciences, 19, 3978.
[Google Scholar] [CrossRef] [PubMed]
[18] Khan, F.S., et al. (2017) Epigenetic Mechanisms Regulating the Development of Hepatocellular Carcinoma and Their Promise for Therapeutics. Hepatology International, 11, 45-53.
[Google Scholar] [CrossRef] [PubMed]
[19] Bedford, M.T. and Clarke, S.G. (2009) Protein Arginine Methylation in Mammals: Who, What, and Why. Molecular Cell, 33, 1-13.
[Google Scholar] [CrossRef] [PubMed]
[20] Su, Z., et al. (2015) Apoptosis, Autophagy, Necroptosis, and Cancer Metastasis. Molecular Cancer, 14, 48.
[Google Scholar] [CrossRef] [PubMed]
[21] Adams, J.M. and Cory, S. (2007) The Bcl-2 Apoptotic Switch in Cancer Development and Therapy. Oncogene, 26, 1324-1337.
[Google Scholar] [CrossRef] [PubMed]
[22] Shigematsu, S., et al. (2011) ZNF689 Suppresses Apoptosis of Hepatocellular Carcinoma Cells through the Down-Regulation of Bcl-2 Family Members. Experimental Cell Research, 317, 1851-1859.
[Google Scholar] [CrossRef] [PubMed]
[23] Brito, A.F., et al. (2016) Targeting Hepatocellular Carcinoma: What Did We Discover So Far? Oncology Reviews, 10, 302.
[Google Scholar] [CrossRef] [PubMed]
[24] Khalilzadeh, B., et al. (2018) Advances in Nanomaterial Based Optical Biosensing and Bioimaging of Apoptosis via Caspase-3 Activity: A Review. Microchimica Acta, 185, 434.
[Google Scholar] [CrossRef] [PubMed]